Durvalumab monotherapy as a third-line treatment for extensive-stage small-cell lung cancer: a case report
Crossref DOI link: https://doi.org/10.21037/apm-20-1244
Published Online: 2020-07
Published Print: 2020-07
Update policy: https://doi.org/10.21037/ame_crossmark_policy
Zhou, Qinfei
Zhao, Jiazheng
Wang, Jie
Bao, Guanai
Gong, Li-Yan